首页|血清miR-296-3p和miR-324-3p表达与肾癌患者临床病理特征及预后的关系

血清miR-296-3p和miR-324-3p表达与肾癌患者临床病理特征及预后的关系

扫码查看
目的:分析血清微小核糖核酸-296-3p(microribonucleic acid-296-3p,miR-296-3p)和微小核糖核酸-324-3p(microribonucleic acid-324-3p,miR-324-3p)表达水平与肾癌患者临床病理特征及预后的关系.方法:选择2017年1月-2020年12月广安市人民医院收治的90例肾癌患者(肾癌组),另选择同时期本院收治的90例肾良性病变患者(良性组),同时期来院接受体检的90例健康体检者(健康组);采用实时荧光定量PCR(RT-PCR)法检测血清中miR-296-3p和miR-324-3p的相对表达量;采用Cox回归分析影响肾癌患者预后的因素;采用Ka-plan-Meier 生存曲线分析miR-296-3p、miR-324-3p水平与肾癌患者预后的关系.结果:健康组、良性组、肾癌组血清miR-296-3p水平依次升高(P<0.05),miR-324-3p水平依次降低(P<0.05).miR-296-3p高表达患者TNM分期为Ⅲ~Ⅳ期的例数显著高于miR-296-3p低表达患者(P<0.05);miR-324-3p低表达患者TNM分期为Ⅲ~Ⅳ期的例数显著高于miR-324-3p高表达患者(P<0.05).生存组miR-296-3p水平显著低于死亡组,miR-324-3p水平显著高于死亡组(P<0.05).TNM分期、miR-296-3p、miR-324-3p是影响肾癌患者生存或死亡的因素(P<0.05).miR-296-3p高表达患者3年总生存率(43.75%,21/48)显著低于miR-296-3p低表达患者(95.24%,40/42)(x2=28.471,P<0.001);miR-324-3p 低表达患者 3 年总生存率(43.48%,20/46)显著低于 miR-324-3p 高表达患者(93.18%,41/44)(x2=27.768,P<0.001).结论:肾癌患者血清 miR-296-3p 水平显著升高,miR-324-3p水平显著降低,且与肾癌患者临床病理特征以及预后相关.
Relationship between serum miR-296-3p and miR-324-3p expression and clinical pathological features and prognosis of renal cell carcinoma patients
Objective:To analyze the relationship between the expression levels of serum microribonucleic acid-296-3p(miR-296-3p),microribonucleic acid-324-3p(miR-324-3p)and the clinical pathological features,prognosis of renal cell carcinoma patients.Methods:A total of 90 renal cancer patients(renal cancer group)admitted to Guang'an People's Hospital from January 2017 to December 2020 were selected.Additionally,90 patients with be-nign renal lesions(benign group)admitted to our hospital were selected,and 90 healthy individuals(healthy group)who underwent physical examinations at our hospital during the same period were collected.Real-time fluores-cence quantitative PCR(RT-PCR)method was applied to detect the relative expression levels of miR-296-3p and miR-324-3p in serum.Cox regression was applied to analyze the factors affecting the prognosis of renal cancer pa-tients.Kaplan-Meier survival curve was applied to analyze the relationship between miR-296-3p,miR-324-3p lev-els and the prognosis of renal cancer patients.Results:The serum miR-296-3p level in the healthy group,benign group,and renal cancer group increased sequentially(P<0.05),while the miR-324-3p level decreased sequentially(P<0.05).The number of TNM stage Ⅲ-Ⅳ in patients with high expression of miR-296-3p was obviously higher than those in patients with low expression of miR-296-3p(P<0.05).The number of TNM stage Ⅲ-Ⅳ in patients with low expression of miR-324-3p was obviously higher than that in patients with high expression of miR-324-3p(P<0.05).The miR-296-3p level in the survival group was obviously lower than that in the death group,while the miR-324-3p level was obviously higher than that in the death group(P<0.05).TNM staging,miR-296-3p,and miR-324-3p were factors that affected the survival or death of renal cancer patients(P<0.05).The 3-year overall survival rate(43.75%,21/48)of patients with high expression of miR-296-3p was obviously lower than that of patients with low expression of miR-296-3p(95.24%,40/42)(x2=28.471,P<0.001).The 3-year overall survival rate of patients with low expression of miR-324-3p(43.48%,20/46)was obviously lower than that of patients with high expression of miR-324-3p(93.18%,41/44)(x2=27.768,P<0.001).Conclusion:High level of serum miR-296-3p and low level of serum miR-324-3p are associated with the clinical pathological features and prognosis of renal cancer patients.

renal cancermicroribonucleic acid-296-3pmicroribonucleic acid-324-3pclinical pathological featuresprognosis

兰东、郭军宏、袁文强、杜建辉

展开 >

广安市人民医院泌尿外科(四川广安,638500)

深圳市宝安区松岗人民医院泌尿外科

肾癌 微小核糖核酸-296-3p 微小核糖核酸-324-3p 临床病理特征 预后

四川省医学青年创新科研课题四川省医疗卫生与健康促进会科研项目

Q22051KY2022QN0139

2024

临床泌尿外科杂志
华中科技大学同济医学院附属协和医院 同济医院

临床泌尿外科杂志

CSTPCD
影响因子:0.734
ISSN:1001-1420
年,卷(期):2024.39(10)